enterovirus

(redirected from EV71)
Also found in: Dictionary, Thesaurus, Medical.

enterovirus

[‚ent·ə·rō′vī·rəs]
(virology)
One of the two subgroups of human picornaviruses; includes the polioviruses, the coxsackieviruses, and the echoviruses.
References in periodicals archive ?
Here, we evaluated the extent to which PMM-034 could inhibit EV71 replication, and then assessed its effect on EV71/VP1 mRNA and protein expressions in rhabdomyosarcoma (RD) cells in vitro.
The most common neurologic diagnoses included encephalomyelitis (40% of patients), brainstem encephalitis (35%), encephalitis (11%), acute flaccid paralysis (7%), and neurogenic pulmonary edema (7%), a particularly severe form of EV71 disease.
Some miRNAs can modulate the replication of EV71 by targeting the viral genome directly.
The new inactivated EV71 vaccine, made by Beijing Vigoo Biological, was developed for use in the Asia-Pacific region, which accounts for most of the serious cases of the disease that can cause potentially fatal meningitis and encephalitis.
The results showed that it prevented 90 percent of cases of hand, foot and mouth disease caused by EV71.
Herein, the activity of punicalagin against EV71 replication was evaluated in vitro and in vivo.
The Ministry of Health's record[4] also showed that there was a higher circulation of the EV71 strain, which has been known to cause infections to the brain, heart and lungs.
The results also support their hypothesis that children who have had an EV71 CNS infection "are more likely to have ADHD-related symptoms, regardless of IQ" (pediatrics 2008;122:e452-8).
Twenty-two children have died from hand, foot and mouth disease and over 3,000 people have been infected in Fuyang city, in the eastern province of Anhui, since a mass outbreak of the EV71 intestinal virus began spreading there in early March.
Another cause of HFMD, EV71 may also cause viral meningitis and, rarely, more serious diseases, such as encephalitis, or a poliomyelitis-like paralysis.
Antibodies that neutralize the EV71 virus were measured in individuals who received both doses of the vaccine.
Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps.